Oncology, Patient, Child, Doctor, Cancer care, Treatment, MDX, Doctor making child laugh

Syndromic testing

Syndromic testing for GI infections with QIAstat-Dx

New: Transform gastrointestinal care with QIAstat-Dx

16 targets*. 1 sample. 1 step. ~1 hour. QIAstat-Dx Gastrointestinal Panel 2 delivers accurate, actionable results quickly and can help you transform your diagnostic process.

With just 200 μL preserved stool sample (Para-Pak C&S), detect and differentiate 16 bacterial, viral and parasitic targets* in about an hour. Our panel offers broad pathogen coverage with an emphasis on clinically actionable targets to help you improve treatment decisions. Get the flyer to learn more.

Download the flyer

The targets

* Results for STEC, E. coli O157 and EPEC are not reported for stool specimens preserved in FecalSwab transport media.

**Also Known as Giardia intestinalis and Giardia duodenalis.

Why is QIAstat-Dx Gastrointestinal Panel 2 right for your patients?

It doesn't get easier than this – QIAstat-Dx workflow***

***When using QIAstat-Dx Gastrointestinal Panel 2, you must select the correct sample type on the instrument touchscreen based on the sample collection device used (Para-Pak C&S or FecalSwab).

We're confident QIAstat-Dx can transform the way you diagnose GI symptoms

Make the right choice for your lab and get in touch today.

I think that [Ct values] can help in the interpretation of the results, in particular in case of co-infections, in order to understand what is the virus or the bacteria that is probably more correlated with the clinical problem.

Liliana Gabrielli, MD, Microbiology Unit, IRCCS Azienda Ospedaliero-Universitaria of Bologna, Policlinico di Sant'Orsola, Italy

It's clear. [The technicians in my lab] love the QIAstat-Dx. Because it's really easy to use… Because they feel that the search for pathogens is smarter.

Laurence Armand-Lefevre, PhD, PharmD, University of Paris Cité, Bichat-Claude Bernard Hospital, France

Disrupt the everyday with digital tech in medicine

More to explore

Contact us

References

1. Orth D, Grif K, Khan AB, Naim A, Dierich MP, Würzner R. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome. Diagn Microbiol Infect Dis. 2007;59(3):235-242. doi:10.1016/j.diagmicrobio.2007.04.013
2. Mühlen S, Dersch P. Treatment Strategies for Infections With Shiga Toxin-Producing Escherichia coli. Front Cell Infect Microbiol. 2020 May 6;10:169. doi: 10.3389/fcimb.2020.00169. PMID: 32435624; PMCID: PMC7218068.
3. European Centre for Disease Prevention and Control Annual Epidemiological Report 2021 – STEC https://www.ecdc.europa.eu/sites/default/files/documents/AER%20STEC%20-%202021.pdf. Accessed February 7, 2024
4. Den Ouden A, Greig DR, Rodwell EV, et al. Escherichia coli encoding Shiga toxin subtype Stx2f causing human infections in England, 2015-2022. J Med Microbiol. 2023;72(6):10.1099/jmm.0.001707. doi:10.1099/jmm.0.001707
5. Engberg J, Vejrum LK, Madsen TV, Nielsen XC. Verification of analytical bacterial spectrum of QIAstat-Dx® GI V2 and Novodiag® Bacterial GE+ V2-0 diagnostic panels. J Antimicrob Chemother. 2021;76(Suppl 3):iii50-iii57. doi:10.1093/jac/dkab242
6. Cointe A, Birgy A, Pascault A, et al. Be aware of Shiga-toxin 2f-producing Escherichia coli: case report and false-negative results with certain rapid molecular panels. Diagn Microbiol Infect Dis. 2020;98(4):115177. doi:10.1016/j.diagmicrobio.2020.115177|
6. From QIAstat-Dx Gastrointestinal Panel 2 (Cat. No. 691412) epidemiology dashboards in QIAsphere Insights, January 2023 – December 2023 for EMEA.*****
8. Johansen RL, Schouw CH, Madsen TV, Nielsen XC, Engberg J. Epidemiology of gastrointestinal infections: lessons learned from syndromic testing, Region Zealand, Denmark. Eur J Clin Microbiol Infect Dis. 2023 Sep;42(9):1091-1101. doi: 10.1007/s10096-023-04642-5. Epub 2023 Jul 19. PMID: 37468662; PMCID: PMC10427544. Study performed using QIAstat-Dx Gastrointestinal Panel (V1).
9. Rogers WS, Westblade LF, Soave R, et al. Impact of a Multiplexed Polymerase Chain Reaction Panel on Identifying Diarrheal Pathogens in Hematopoietic Cell Transplant Recipients. Clin Infect Dis. 2020;71(7):1693-1700. doi:10.1093/cid/ciz1068

*****These studies were conducted using QIAstat-Dx Gastrointestinal Panel 2 (Cat. No. 691412) or QIAstat-Dx Gastrointestinal Panel (V1). These CE-IVD products are not available in the U.S.

QIAsphere data from connected institutions were used for scientific research purposes only after applying proper de-identification procedures and anonymization techniques, in accordance with HIPAA and GDPR privacy and data protection rules. Data is aggregated from QIAsphere-connected QIAstat-Dx instruments only.

Unless otherwise indicated, data cited pertains to the use of a device from another manufacturer.